Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment

NCT05119738 · clinicaltrials.gov ↗

UNKNOWN

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Sars-CoV-2 Infection

Interventions

BIOLOGICAL: Three doses of BNT162b2 (observational)
BIOLOGICAL: Two doses of Coronavac and one dose BNT162b2 (observational)

Sponsor

Pontificia Universidad Catolica de Chile